chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: arm hurt; tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired) and PAIN IN EXTREMITY (arm hurt) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 27-Feb-2021, the patient experienced FATIGUE (tired) and PAIN IN EXTREMITY (arm hurt). On 28-Feb-2021, FATIGUE (tired) had resolved. On 01-Mar-2021, PAIN IN EXTREMITY (arm hurt) had resolved. Not Provided          Concomitant medication information was not reported. Treatment information as not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-036914 (E2B Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Non-significant follow up appended.Reporter Contact info added; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-036914:Wife case
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash
Clinical narrative: Pain on arm; Very itchy rash on both armpits, around her neck and below her breasts; Very itchy rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Very itchy rash on both armpits, around her neck and below her breasts), PAIN IN EXTREMITY (Pain on arm) and PRURITUS (Very itchy rash) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced RASH (Very itchy rash on both armpits, around her neck and below her breasts) and PRURITUS (Very itchy rash). On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain on arm). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) at a dose of 1 dosage form. At the time of the report, RASH (Very itchy rash on both armpits, around her neck and below her breasts) had not resolved, PAIN IN EXTREMITY (Pain on arm) outcome was unknown and PRURITUS (Very itchy rash) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 08-Mar-2021: No specific follow-up information recorded.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: lymph node on his left side was swollen; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph node on his left side was swollen) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced LYMPHADENOPATHY (lymph node on his left side was swollen). At the time of the report, LYMPHADENOPATHY (lymph node on his left side was swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. No treatment details were reported.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Skin lesion
Clinical narrative: red-dark to purplish lesion on injection site, pt has progressively increased in size and extends from the injection site in the upper arm to elbow and even beyond; This spontaneous case was reported by a consumer and describes the occurrence of SKIN LESION (red-dark to purplish lesion on injection site, pt has progressively increased in size and extends from the injection site in the upper arm to elbow and even beyond) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced SKIN LESION (red-dark to purplish lesion on injection site, pt has progressively increased in size and extends from the injection site in the upper arm to elbow and even beyond). At the time of the report, SKIN LESION (red-dark to purplish lesion on injection site, pt has progressively increased in size and extends from the injection site in the upper arm to elbow and even beyond) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided. Patient stated that not taking any medications for the symptom
Sex: M
Vaccine: COVID19
Symptoms: Blepharospasm
Clinical narrative: left upper eyelid twitching uncontrollably and involuntarily; This spontaneous case was reported by a consumer and describes the occurrence of BLEPHAROSPASM (left upper eyelid twitching uncontrollably and involuntarily) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced BLEPHAROSPASM (left upper eyelid twitching uncontrollably and involuntarily). At the time of the report, BLEPHAROSPASM (left upper eyelid twitching uncontrollably and involuntarily) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Nasopharyngitis, Pyrexia
Clinical narrative: Very weak; Felt like a fever; Shaking; Cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold), ASTHENIA (Very weak), PYREXIA (Felt like a fever) and CHILLS (Shaking) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced NASOPHARYNGITIS (Cold), PYREXIA (Felt like a fever) and CHILLS (Shaking). On 08-Mar-2021, the patient experienced ASTHENIA (Very weak). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK, q6h. At the time of the report, NASOPHARYNGITIS (Cold), ASTHENIA (Very weak), PYREXIA (Felt like a fever) and CHILLS (Shaking) outcome was unknown.            No relevant concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose fluctuation, Hyperglycaemia
Clinical narrative: Blood sugar levels of 178 after receiving the second dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (Blood sugar levels of 178 after receiving the second dose of the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERGLYCAEMIA (Blood sugar levels of 178 after receiving the second dose of the vaccine). At the time of the report, HYPERGLYCAEMIA (Blood sugar levels of 178 after receiving the second dose of the vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose fluctuation: 178 (Inconclusive) After the second shot it was 178..         Concomitant medication information was not reported. Treatment information as not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Ocular hyperaemia, Pyrexia
Clinical narrative: Blood in the eye; Fever; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (Blood in the eye) and PYREXIA (Fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced OCULAR HYPERAEMIA (Blood in the eye) and PYREXIA (Fever). At the time of the report, OCULAR HYPERAEMIA (Blood in the eye) and PYREXIA (Fever) outcome was unknown.            No concomitant medications were reported.  No treatment information was reported.  Action taken with mRNA-1273 in response to the events was not Applicable
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Muscle spasms, Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore arm), diarrhea and muscle spasms (cramps) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included diverticulitis and irritable bowel syndrome. On Feb 8, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 8, 2021, patient experienced pain in extremity (sore arm). On an unknown date, patient experienced diarrhea and muscle spasms (cramps). At the time of the report,  pain in extremity (sore arm), diarrhea and muscle spasms (cramps) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity
Clinical narrative: Really sore arm; Cold chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Really sore arm) and CHILLS (Cold chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00A21A) for COVID-19 vaccination.     The patient's past medical history was not reported .  Concomitant products included RIVAROXABAN (XARELTO), IRON, VITAMIN D3, MONTELUKAST SODIUM (SINGULAIR), DULOXETINE HYDROCHLORIDE (CYMBALTA), TOPIRAMATE (TOPAMAX), BACLOFEN, TRAZODONE, PREGABALIN (LYRICA), CEFALEXIN (CEPHALEXINE), OMEPRAZOLE, DICLOFENAC (VOLTAREN [DICLOFENAC]) and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (Really sore arm) and CHILLS (Cold chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Really sore arm) and CHILLS (Cold chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Condition aggravated, Eye disorder, Headache
Clinical narrative: Started to see something was wrong with my eyes; In the afternoon it got really bad; Headaches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of EYE DISORDER (Started to see something was wrong with my eyes), CONDITION AGGRAVATED (In the afternoon it got really bad), HEADACHE (Headaches) and CHILLS (Chills) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  .  Concomitant products included SERTRALINE HYDROCHLORIDE (SERTRALINE A) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced HEADACHE (Headaches) and CHILLS (Chills). On 05-Mar-2021, the patient experienced EYE DISORDER (Started to see something was wrong with my eyes) and CONDITION AGGRAVATED (In the afternoon it got really bad). On 03-Mar-2021, CHILLS (Chills) had resolved. On 04-Mar-2021, HEADACHE (Headaches) had resolved. On 06-Mar-2021, EYE DISORDER (Started to see something was wrong with my eyes) and CONDITION AGGRAVATED (In the afternoon it got really bad) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Pain, Pyrexia
Clinical narrative: Achy; Feels terrible; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy), FEELING ABNORMAL (Feels terrible), CHILLS (Chills) and PYREXIA (Fever) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (Achy), FEELING ABNORMAL (Feels terrible), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, PAIN (Achy), FEELING ABNORMAL (Feels terrible), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Neck pain, Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: neck pain; high fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain), CHILLS (chills) and PYREXIA (high fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, LOSARTAN, METFORMIN and VITAMIN D3 for an unknown indication.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced CHILLS (chills). On 01-Mar-2021, the patient experienced NECK PAIN (neck pain) and PYREXIA (high fever). The patient was treated with HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN) at a dose of UNK dosage form; IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of UNK dosage form and PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 23-Feb-2021, CHILLS (chills) had resolved. On 07-Mar-2021, NECK PAIN (neck pain) had resolved. At the time of the report, PYREXIA (high fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, SARS-CoV-2 antibody test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye pain, Feeling abnormal, Skin swelling, Skin wrinkling
Clinical narrative: skin at the bottom is wrinkly; next day hurt even worse; red; puffy; right eye hurting; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (right eye hurting), FEELING ABNORMAL (next day hurt even worse), ERYTHEMA (red), SKIN SWELLING (puffy) and SKIN WRINKLING (skin at the bottom is wrinkly) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced EYE PAIN (right eye hurting). On 05-Mar-2021, the patient experienced FEELING ABNORMAL (next day hurt even worse), ERYTHEMA (red) and SKIN SWELLING (puffy). On an unknown date, the patient experienced SKIN WRINKLING (skin at the bottom is wrinkly). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, EYE PAIN (right eye hurting), FEELING ABNORMAL (next day hurt even worse), ERYTHEMA (red), SKIN SWELLING (puffy) and SKIN WRINKLING (skin at the bottom is wrinkly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs are progesterone birth control.   Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site scab, Vaccination site swelling
Clinical narrative: Scab at the injection site; Itchinh/wanted to "tear her arm apart" from the itching; Swelling; Redness; Burning; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SCAB (Scab at the injection site), VACCINATION SITE PRURITUS (Itchinh/wanted to "tear her arm apart" from the itching), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PAIN (Burning) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (50 years ago), Drug hypersensitivity (Lidocaine), Dry skin, Asthma since 1988, Arthritis (Osteoarthritis) since 1982, Gastrointestinal disorder NOS (IBS) since 2015, Anxiety since 1960 and Heart disease, unspecified since 2004. Concomitant products included ISOSORBIDE, MACROGOL 3350 (PURELAX), ACETYLSALICYLIC ACID (BABY ASPIRIN) and ALPRAZOLAM for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 23-Feb-2021, the patient experienced VACCINATION SITE SCAB (Scab at the injection site), VACCINATION SITE PRURITUS (Itchinh/wanted to "tear her arm apart" from the itching), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PAIN (Burning). On 24-Feb-2021, VACCINATION SITE SCAB (Scab at the injection site), VACCINATION SITE PRURITUS (Itchinh/wanted to "tear her arm apart" from the itching), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE PAIN (Burning) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow up received information about ethnicity and Previous allergy history, Vaccine facility information and Concomitant medications details were updated.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Warmness near the injection site; Redness near the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warmness near the injection site) and VACCINATION SITE ERYTHEMA (Redness near the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027l20a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CIPROFLOXACIN and LOSARTAN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warmness near the injection site) and VACCINATION SITE ERYTHEMA (Redness near the injection site). At the time of the report, VACCINATION SITE WARMTH (Warmness near the injection site) and VACCINATION SITE ERYTHEMA (Redness near the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Balance disorder, Dizziness, Dizziness postural, Vertigo
Clinical narrative: COULD NOT STAND; VERTIGO; no balance; ADVERSE REACTION; EXTREMLY DIZZY; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (ADVERSE REACTION), DIZZINESS (EXTREMLY DIZZY), DIZZINESS POSTURAL (COULD NOT STAND), VERTIGO (VERTIGO) and BALANCE DISORDER (no balance) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ADVERSE REACTION (ADVERSE REACTION) and DIZZINESS (EXTREMLY DIZZY). On 03-Mar-2021, the patient experienced DIZZINESS POSTURAL (COULD NOT STAND), VERTIGO (VERTIGO) and BALANCE DISORDER (no balance). At the time of the report, ADVERSE REACTION (ADVERSE REACTION), DIZZINESS (EXTREMLY DIZZY), DIZZINESS POSTURAL (COULD NOT STAND), VERTIGO (VERTIGO) and BALANCE DISORDER (no balance) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not reported.   Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Decreased appetite, Dry throat, Illness
Clinical narrative: She got real sick; Felt hot all over; Felt sick like she had the flu; Throat was dry; Did not want to eat anything; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (She got real sick), BODY TEMPERATURE INCREASED (Felt hot all over), ILLNESS (Felt sick like she had the flu), DRY THROAT (Throat was dry) and DECREASED APPETITE (Did not want to eat anything) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (She got real sick), BODY TEMPERATURE INCREASED (Felt hot all over), ILLNESS (Felt sick like she had the flu), DRY THROAT (Throat was dry) and DECREASED APPETITE (Did not want to eat anything). At the time of the report, ILLNESS (She got real sick), BODY TEMPERATURE INCREASED (Felt hot all over), ILLNESS (Felt sick like she had the flu), DRY THROAT (Throat was dry) and DECREASED APPETITE (Did not want to eat anything) outcome was unknown.            Treatment details included Cold towel.  No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling hot, Headache, Lymphadenopathy
Clinical narrative: her face started itching; her face started swelling; her whole neck was all red; her whole neck was swollen; her face is hot; her lymph nodes in both arm swollen; headache; fever; fatigue; chills; pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm), FATIGUE (fatigue), CHILLS (chills), LYMPHADENOPATHY (her lymph nodes in both arm swollen) and HEADACHE (headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Allergy and Sinus operation. Concomitant products included LORATADINE, PREGABALIN and MONTELUKAST for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm). On 15-Feb-2021, the patient experienced FATIGUE (fatigue) and CHILLS (chills). On 16-Feb-2021, the patient experienced LYMPHADENOPATHY (her lymph nodes in both arm swollen), HEADACHE (headache) and PYREXIA (fever). On 20-Feb-2021, the patient experienced PRURITUS (her face started itching), SWELLING FACE (her face started swelling), RASH (her whole neck was all red), SWELLING (her whole neck was swollen) and FEELING HOT (her face is hot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 14-Feb-2021, PAIN IN EXTREMITY (pain in the arm) had resolved. On 16-Feb-2021, CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, FATIGUE (fatigue), LYMPHADENOPATHY (her lymph nodes in both arm swollen), HEADACHE (headache), PRURITUS (her face started itching), SWELLING FACE (her face started swelling), RASH (her whole neck was all red), SWELLING (her whole neck was swollen) and FEELING HOT (her face is hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Pyrexia, Rash, Swelling
Clinical narrative: her face started itching; her face started swelling; her whole neck was all red; her whole neck was swollen; her face is hot; her lymph nodes in both arm swollen; headache; fever; fatigue; chills; pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm), FATIGUE (fatigue), CHILLS (chills), LYMPHADENOPATHY (her lymph nodes in both arm swollen) and HEADACHE (headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Allergy and Sinus operation. Concomitant products included LORATADINE, PREGABALIN and MONTELUKAST for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm). On 15-Feb-2021, the patient experienced FATIGUE (fatigue) and CHILLS (chills). On 16-Feb-2021, the patient experienced LYMPHADENOPATHY (her lymph nodes in both arm swollen), HEADACHE (headache) and PYREXIA (fever). On 20-Feb-2021, the patient experienced PRURITUS (her face started itching), SWELLING FACE (her face started swelling), RASH (her whole neck was all red), SWELLING (her whole neck was swollen) and FEELING HOT (her face is hot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 14-Feb-2021, PAIN IN EXTREMITY (pain in the arm) had resolved. On 16-Feb-2021, CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, FATIGUE (fatigue), LYMPHADENOPATHY (her lymph nodes in both arm swollen), HEADACHE (headache), PRURITUS (her face started itching), SWELLING FACE (her face started swelling), RASH (her whole neck was all red), SWELLING (her whole neck was swollen) and FEELING HOT (her face is hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: her face started itching; her face started swelling; her whole neck was all red; her whole neck was swollen; her face is hot; her lymph nodes in both arm swollen; headache; fever; fatigue; chills; pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm), FATIGUE (fatigue), CHILLS (chills), LYMPHADENOPATHY (her lymph nodes in both arm swollen) and HEADACHE (headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Allergy and Sinus operation. Concomitant products included LORATADINE, PREGABALIN and MONTELUKAST for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm). On 15-Feb-2021, the patient experienced FATIGUE (fatigue) and CHILLS (chills). On 16-Feb-2021, the patient experienced LYMPHADENOPATHY (her lymph nodes in both arm swollen), HEADACHE (headache) and PYREXIA (fever). On 20-Feb-2021, the patient experienced PRURITUS (her face started itching), SWELLING FACE (her face started swelling), RASH (her whole neck was all red), SWELLING (her whole neck was swollen) and FEELING HOT (her face is hot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 14-Feb-2021, PAIN IN EXTREMITY (pain in the arm) had resolved. On 16-Feb-2021, CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, FATIGUE (fatigue), LYMPHADENOPATHY (her lymph nodes in both arm swollen), HEADACHE (headache), PRURITUS (her face started itching), SWELLING FACE (her face started swelling), RASH (her whole neck was all red), SWELLING (her whole neck was swollen) and FEELING HOT (her face is hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: Sore arm/ leg aches; Headache; Fever; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm/ leg aches), HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Tiredness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm/ leg aches), HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 27-Feb-2021, HEADACHE (Headache) and FATIGUE (Tiredness) had resolved. On 07-Mar-2021, PAIN IN EXTREMITY (Sore arm/ leg aches) had resolved. At the time of the report, PYREXIA (Fever) outcome was unknown.            No concomitant medications were provided.   This case was linked to MOD-2021-036877 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Non-significant follow up appended.; Sender's Comments:  MOD-2021-036877:Husband case
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Peripheral swelling, Rash erythematous
Clinical narrative: feet are swollen just a little; red rash on lower legs and feet; extreme fatigue; nausea; chills; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (feet are swollen just a little), RASH ERYTHEMATOUS (red rash on lower legs and feet), FATIGUE (extreme fatigue), NAUSEA (nausea) and CHILLS (chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PERIPHERAL SWELLING (feet are swollen just a little), RASH ERYTHEMATOUS (red rash on lower legs and feet), FATIGUE (extreme fatigue), NAUSEA (nausea) and CHILLS (chills). At the time of the report, PERIPHERAL SWELLING (feet are swollen just a little), RASH ERYTHEMATOUS (red rash on lower legs and feet), FATIGUE (extreme fatigue), NAUSEA (nausea) and CHILLS (chills) outcome was unknown.            No treatment information was provided.  No concomitant medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Added TCR: Spoke to the patient's sister, the patient still has swelling of the feet, but the rest ofthe events were resolved. Does not have email
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: Reaction in her arm, Moderna arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Reaction in her arm, Moderna arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Reaction in her arm, Moderna arm). At the time of the report, LIMB DISCOMFORT (Reaction in her arm, Moderna arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Heart rate increased, Hypopnoea, Nausea
Clinical narrative: Shallow breathing; my pulse was very fast; Tenderness at the injection site; Pain at the injection area; Had expected symptoms; Had diarrhea lasted for full day and the following day; Fatigue; Nausea; Fever; Experienced rapid pulse; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had expected symptoms), DIARRHOEA (Had diarrhea lasted for full day and the following day), HEART RATE INCREASED (Experienced rapid pulse), HYPOPNOEA (Shallow breathing) and HEART RATE INCREASED (my pulse was very fast) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METOPROLOL for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced HEART RATE INCREASED (Experienced rapid pulse). On 02-Mar-2021, the patient experienced VACCINATION COMPLICATION (Had expected symptoms), DIARRHOEA (Had diarrhea lasted for full day and the following day), FATIGUE (Fatigue), NAUSEA (Nausea) and PYREXIA (Fever). On 04-Mar-2021, the patient experienced HYPOPNOEA (Shallow breathing), HEART RATE INCREASED (my pulse was very fast), VACCINATION SITE PAIN (Tenderness at the injection site) and VACCINATION SITE PAIN (Pain at the injection area). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Had expected symptoms), DIARRHOEA (Had diarrhea lasted for full day and the following day), HEART RATE INCREASED (Experienced rapid pulse), HYPOPNOEA (Shallow breathing), HEART RATE INCREASED (my pulse was very fast), FATIGUE (Fatigue), NAUSEA (Nausea), PYREXIA (Fever), VACCINATION SITE PAIN (Tenderness at the injection site) and VACCINATION SITE PAIN (Pain at the injection area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination complication, Vaccination site pain
Clinical narrative: Shallow breathing; my pulse was very fast; Tenderness at the injection site; Pain at the injection area; Had expected symptoms; Had diarrhea lasted for full day and the following day; Fatigue; Nausea; Fever; Experienced rapid pulse; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had expected symptoms), DIARRHOEA (Had diarrhea lasted for full day and the following day), HEART RATE INCREASED (Experienced rapid pulse), HYPOPNOEA (Shallow breathing) and HEART RATE INCREASED (my pulse was very fast) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METOPROLOL for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced HEART RATE INCREASED (Experienced rapid pulse). On 02-Mar-2021, the patient experienced VACCINATION COMPLICATION (Had expected symptoms), DIARRHOEA (Had diarrhea lasted for full day and the following day), FATIGUE (Fatigue), NAUSEA (Nausea) and PYREXIA (Fever). On 04-Mar-2021, the patient experienced HYPOPNOEA (Shallow breathing), HEART RATE INCREASED (my pulse was very fast), VACCINATION SITE PAIN (Tenderness at the injection site) and VACCINATION SITE PAIN (Pain at the injection area). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Had expected symptoms), DIARRHOEA (Had diarrhea lasted for full day and the following day), HEART RATE INCREASED (Experienced rapid pulse), HYPOPNOEA (Shallow breathing), HEART RATE INCREASED (my pulse was very fast), FATIGUE (Fatigue), NAUSEA (Nausea), PYREXIA (Fever), VACCINATION SITE PAIN (Tenderness at the injection site) and VACCINATION SITE PAIN (Pain at the injection area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Migraine, Nausea, Pain, Pruritus
Clinical narrative: her lymph nodes are very swollen and painful on her right side; nausea; itchiness; swelling; extreme pain on her right arm and back; migraine; fever -100°f; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness), SWELLING (swelling), PAIN (extreme pain on her right arm and back), MIGRAINE (migraine) and PYREXIA (fever -100°f) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high, Cholesterol and Fibromyalgia.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PRURITUS (itchiness), SWELLING (swelling), PAIN (extreme pain on her right arm and back), MIGRAINE (migraine) and PYREXIA (fever -100°f). On 08-Mar-2021, the patient experienced NAUSEA (nausea). On an unknown date, the patient experienced LYMPH NODE PAIN (her lymph nodes are very swollen and painful on her right side). The patient was treated with LORAZEPAM (ATIVAN) for Adverse event, at a dose of 1.25 milligram. At the time of the report, PRURITUS (itchiness), SWELLING (swelling), PAIN (extreme pain on her right arm and back), MIGRAINE (migraine), PYREXIA (fever -100°f), NAUSEA (nausea) and LYMPH NODE PAIN (her lymph nodes are very swollen and painful on her right side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included High blood pressure medication and Cholesterol medication for an unknown indication.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling
Clinical narrative: her lymph nodes are very swollen and painful on her right side; nausea; itchiness; swelling; extreme pain on her right arm and back; migraine; fever -100°f; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness), SWELLING (swelling), PAIN (extreme pain on her right arm and back), MIGRAINE (migraine) and PYREXIA (fever -100°f) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high, Cholesterol and Fibromyalgia.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PRURITUS (itchiness), SWELLING (swelling), PAIN (extreme pain on her right arm and back), MIGRAINE (migraine) and PYREXIA (fever -100°f). On 08-Mar-2021, the patient experienced NAUSEA (nausea). On an unknown date, the patient experienced LYMPH NODE PAIN (her lymph nodes are very swollen and painful on her right side). The patient was treated with LORAZEPAM (ATIVAN) for Adverse event, at a dose of 1.25 milligram. At the time of the report, PRURITUS (itchiness), SWELLING (swelling), PAIN (extreme pain on her right arm and back), MIGRAINE (migraine), PYREXIA (fever -100°f), NAUSEA (nausea) and LYMPH NODE PAIN (her lymph nodes are very swollen and painful on her right side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included High blood pressure medication and Cholesterol medication for an unknown indication.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: High fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High fever) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Had Covid 2 months before vaccination and completely recovered from it.).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (High fever). At the time of the report, PYREXIA (High fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Nervousness, Paraesthesia, Pyrexia
Clinical narrative: tingling on his fingers of his left arm only; His pinky is a little bit shaky when he has his arm stretched; fever; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling on his fingers of his left arm only), NERVOUSNESS (His pinky is a little bit shaky when he has his arm stretched) and PYREXIA (fever) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced PYREXIA (fever). On 06-Mar-2021, the patient experienced PARAESTHESIA (tingling on his fingers of his left arm only) and NERVOUSNESS (His pinky is a little bit shaky when he has his arm stretched). At the time of the report, PARAESTHESIA (tingling on his fingers of his left arm only), NERVOUSNESS (His pinky is a little bit shaky when he has his arm stretched) and PYREXIA (fever) outcome was unknown.            Concomitant medication information was not reported. Treatment information as not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: Feeling Very Weak; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Feeling Very Weak) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced ASTHENIA (Feeling Very Weak). At the time of the report, ASTHENIA (Feeling Very Weak) outcome was unknown. Not Provided          Concomitant medications were not provided by the reporter Treatment information includes Fluids and Tylenol   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: No specific follow-up information recorded.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Erythema, Induration, Injection site warmth, Swelling
Clinical narrative: Induration; Redness/erythema; Heat; Swelling; This spontaneous case was reported by a health care professional and describes the occurrence of INDURATION (Induration), ERYTHEMA (Redness/erythema), INJECTION SITE WARMTH (Heat) and SWELLING (Swelling) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INDURATION (Induration), ERYTHEMA (Redness/erythema), INJECTION SITE WARMTH (Heat) and SWELLING (Swelling). At the time of the report, INDURATION (Induration), ERYTHEMA (Redness/erythema), INJECTION SITE WARMTH (Heat) and SWELLING (Swelling) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: unknown (Low) low grade temperature.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.  Concomitant product was unknown  by the reporter.  Patient gave consent to safety for follow-up.